Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant

Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant

Item
http://www.wikidata.org/entity/Q27022992
Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/-R) is an effective treatment with low toxicity in Hodgkin's and non-Hodgkin's lymphomas.Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program.Recurrent Hodgkin lymphoma: toward a new definition of candidates for autologous stem cell transplant in the era of positron emission tomography scan and novel agents.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC).Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients.Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma.Brentuximab vedotin consolidation post-autologous stem cell transplant in Hodgkin lymphoma patients at risk of residual disease: number needed to treat.Response to the letter by Adams and Kwee, entitled: "Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma".CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment.
P2860

Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant

Item
http://www.wikidata.org/entity/Q27022992
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Classical Hodgkin's lymphoma: ...... tients eligible for transplant
@ast
Classical Hodgkin's lymphoma: ...... tients eligible for transplant
@en
Classical Hodgkin's lymphoma: ...... tients eligible for transplant
@nl
type
label
Classical Hodgkin's lymphoma: ...... tients eligible for transplant
@ast
Classical Hodgkin's lymphoma: ...... tients eligible for transplant
@en
Classical Hodgkin's lymphoma: ...... tients eligible for transplant
@nl
prefLabel
Classical Hodgkin's lymphoma: ...... tients eligible for transplant
@ast
Classical Hodgkin's lymphoma: ...... tients eligible for transplant
@en
Classical Hodgkin's lymphoma: ...... tients eligible for transplant
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Classical Hodgkin's lymphoma: ...... tients eligible for transplant
@en
P2093
P2860
P304
P31
P356
10.3324/HAEMATOL.2012.072090
P407
P433
P478
P50
P577
P5875
P698
P932